Global enterprises are set to enter a new phase of artificial intelligence adoption in 2026, with AI systems expected to operate at scale across core business functions, according to Sandhya Arun, ...
The efficacy of an implanted biomaterial is dependent on its ability to mitigate the foreign body response (FBR). Consequently, advancements in biomaterials design often focus on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback